D
OSE response has been used widely for determining the potencies of both inhibitors and stimulants in microbiology, pharmacology, vitamin assays, etc. It has also been used for explaining and determining the nature of action of many different types of compounds (Ariens et al., 1955) . However, dose response has not been applied to the study of embryonic development. It appeared that a detailed study of the lethal response of the developing chick embryo to dose variations of a metabolic inhibitor would indicate over-all metabolic changes in the embryo as related to the particular inhibition. 2-ethyl-5-methylbenzimidazole (EMB) was chosen for the study since it is highly inhibitory to the chick embryo (Boggs and Shorb, 1956; Billett and Perry, 1957; Blackwood and Shorb, 1958) causing numerous malformations which predominately involve initial stages of differentiation (Blackwood, 1960 a, b fully understood. However, information available indicates that they primarily inhibit some biosynthetic process (es) involving nucleic acid and/or nucleoprotein rather than 0« uptake or fructolysis (Tamm et al., 1953; Tamm and Tyrrell, 1954; Abbott and Dodson, 1954; Blackwood and Harris, 1960) .
MATERIALS AND METHODS
EMB was injected through the air cell into eggs which had been incubated for varying lengths of time from 0 to 8 days. The eggs were candled periodically from the 4th day of incubation until the 18th day. For all treatments made at 0 to 3 days of incubation, each infertile or dead embryonated egg was removed, opened, and examined. All data presented are based on percent dead at 18 days. Hatchability data were collected, but were more erratic than data describing percent dead at 18 days. Each treatment was repeated 2 to 9 times and each repeat involved 15 to 20 fertile eggs. Each point of the succeeding graphs represents the arithmetic average of the repeats. Information on the details of the injection procedure, incubation conditions, dissolution of the compound, and control experiments have been given elsewhere (Blackwood, 1958; Blackwood and Shorb, 1958) .
The data reported in this paper resulting from treatments of eggs incubated from 0 to 5 days were obtained at a single season (late fall and early winter) and the eggs were from a random-bred strain of White Leghorn hens mated to either random-bred or a flightless strain of White Leghorn males. The data from treatments at 6 to 8 days were obtained at various times of the year and the eggs were from various strains of chickens. Wet weights of the embryo and of the total embryonic tissue (i.e. embryo plus extra embryonic membranes) were used for estimating the "concentration" of EMB at the various doses and ages. Weights were taken from Byerly (1932) since this was a very complete study involving over 2,000 embryos of different breeds.
RESULTS
Since in earlier experiments a difference was found in the lethal effect of EMB which could be related to genetic and/ or seasonal differences (Blackwood and Shorb, 1958) , a series of experiments was made at a single season of the year in which the lethality of EMB in eggs from pure random-bred embryos was compared with that in eggs from random-bred hens crossed with flightless males. Dose response data indicated that the flightless cross embryos were more susceptible than the pure random-bred embryos when the compound was administered at 0 and \\ days of incubation but not at 2 or 3 days ( Fig. 1) . Thus the subsequent data to be presented here were taken only from treatments of the hybrid embryos at 0, 1, and \\ days, but data from different strains were combined for all ages after \\ days.
The method of expression was found to be of great importance in interpreting the same data. Figure 2 shows that age at treatment influenced dose effect when the results were based on dose per embryo. The peak of effectiveness for each dose shifted gradually as the dose was increased: \-\\ to l §-2, to 2-3, to 2-5 days. Figure 3 shows the dose response curves at various ages with results again based on dose per embryo. It can be seen that the general slope of the curves gradually increased from 0 to 2 days where it reached a maximum. The curves for succeeding days shifted to the right but maintained approximately the same slope as that of 2 days. When the data are calculated on the basis of amount of inhibitor per unit weight of total embryonic tissue (embryo plus membranes), log dose response curves are obtained for the various ages as shown in Fig. 4 . It is evident that the curves, when thus plotted, are for the most part straight lines and that the slopes of 0, 1, and lj days are approximately the same, and less than those of the succeeding days which too are nearly the same; i.e., increases in slopes occur between 1| and 2 days. This change in slopes is of much greater magnitude if the values are plotted on linear graph. The LDso's taken from imum in dose effectiveness is reached at 2 days (l §-3 days) and then gradually decreases or, in other words, the embryo is most susceptible to EMB at 2 days, and then becomes increasingly resistant. However, the LDso's taken from Fig. 4 (increase in total weight considered) and plotted as a logarithmic curve in Fig. 5 give a straight line with a negative slope indicating that the embryonic tissue became progressively more sensitive to EMB through 8 days. The irregularity of the values at 6, 7, and 8 days may be due to the fact that data for these ages was collected at different times of the year and from different birds. However, the logarithmic plot of LD 50 's based on embryo weights (i.e. without membranes) (Fig. 5 ) results in two straight lines of different slopes which intersect at the 4th day. Table 1 shows the numerical LD 6 o's based on "concentration" in the embryo alone and in total embryonic tissue at various periods of incubation. The corresponding wet weights are also presented. The magnitude of decrease of LD 50 through the first 2-3 days is obvious, while afterwards to 8 days it is only slight. This is in sharp contrast to increase in weight. effect of EMB. The fact that the eggs were laid in the same season by the same breed and strain of hens and that the embryos differed only in respect to the male chromosomal contribution indicate that the genetic effect lay entirely within the embryo itself and not in the nutrient composition of the eggs or in the length of time the egg was retained within the hen or other indirect influences from the hen. This suggests that at least part of the variation in lethality of EMB at 0 day of incubation previously ascribed to genetic and/or seasonal differences (Blackwood and Shorb, 1958) was due to embryonic genetic differences.
The interpretation of dose response curves and LD 60 curves derived from the dose response curves is greatly dependent upon a consideration of change in "concentration" of inhibitor in embryonic tissue due to an increase in tissue mass. This assumes that the amount of inhibitor distributed throughout the non-living portion of the egg is constant regardless of the age of the embryo at the time the compound is administered. Although this assumption may not be valid, it is more accurate than ignoring the enormous weight gain during development. Without considering weight it would appear that the embryo becomes increasingly sensitive to EMB until 2 days and then becomes progressively resistant. However, with this consideration one finds that the embryo continues to increase in sensitivity through 8 days (the period tested). Nevertheless, the greatest increase in susceptibility of the embryo to EMB occurred during the first 2 days as indicated by both the slopes of the dose response curves and the LD 60 values.
This tremendous increase in susceptibility occurring during the first 2-3 days could be due to the beginning functioning circulatory system which results in a more efficient distribution of the inhibitor or to a progressive change in metabolism of the embryo which becomes almost complete at 2-3 days. A change in metabolism toward susceptibility could result from the development of new vital metabolic systems which are more susceptible to the inhibitor or to a change in metabolism so that the compound is less readily detoxified. Or, combinations of any or all of these factors could account for this change. The idea of the development of new metabolic systems is supported by the conclusion of Spratt (1950) , derived from studies on in vitro cultured chick embryos. He showed that as the embryo reaches a higher level of differentiation it is more sensitive to metabolic inhibitors or other adverse conditions. The further increase in sensitivity through 8 days but at a progressively decreasing rate could indicate the corresponding over-all increase in differentiation. If this assumption is correct, then the LD 60 logarithmic curve is a negative measure of differentiation in the chick embryo. The differentiation curve would be either a logarithmic straight line or a line broken on the 4th day of incubation with the same positive slopes. The reason for the break in the LD 6 o logarithmic curve which was based on the "concentration" of inhibitor in the embryo alone is not understood. One might assume that it corresponds to extra embryonic membrane growth, but logarithmic plots of total embryonic growth (including membranes) and of simple embryonic growth do not show differences corresponding to the LD50 logarithmic plots. Since EMB is a known inhibitor of extraembryonic membrane development (Blackwood, 1960b) , it is believed that the unbroken LD 60 line is the more accurate of the two. This difference between the two lines could indicate that EMB is also selectively inhibiting differentiation in the 3-8 day embryo as well as the 0-2 day embryo as previously shown (Blackwood, 1960b) . Thus, the apparent progressive increasing resistance beginning at 3 days, as seen in the LD 6 o curve based on dose per embryo, is more than a mere diluting out of the inhibitor by increase in tissue mass.
It is believed that a study of dose response data can be a valuable approach for elucidating over-all embryonic metabolism.
SUMMARY
Lethal dose response of the chick embryo to 2-ethyl-5-methylbenzimidazole was determined daily for 0-8 days of incubation by injecting the compound into fertile eggs at the varying periods of incubation. The calculated estimations of inhibitor "concentration" in embryonic tissue was found to be extremely impor-tant for interpreting results. Dose response data based on dose per embryo indicated that the embryo became increasingly sensitive up to 2 days of incubation and thereafter became increasingly resistant. However, dose response data based on "concentration" of inhibitor in embryonic tissue showed that the embryo became increasingly susceptible to the inhibitor up to 8 days, but at a decreasing rate, with the greatest rate occurring during the first 2 days. The LD 6 o logarithmic curve based on "concentration" of inhibitor in embryo plus membranes differed from that based on "concentration" in embryo alone, and could not be correlated with simple membrane growth.
Embryonic genetic differences were found to influence the lethality of the benzimidazole at 0 and 1| days of incubation but not at 2 or 3 days.
